| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
1.9895 -0.1 (-0.05%) |
07-19 15:17 |
|
Open: |
2.15 |
Pre close: |
2.09 |
Target:
|
2.98 
|
|
High: |
2.15 |
Low: |
1.98 |
Resistance:
|
2.55
3.11
|
|
Volume: |
15,126 |
Market Cap: |
8M |
Support:
|
1.64
1.36
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.07
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
2.42 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
2.46 |
Stochastic Oscillator |
%K(14,3):
|
9.24 |
|
MA(250): |
2.95 |
%D(3): |
9.69 |
|
Average Volume(K) |
3-Month: |
11974
|
52-Week |
High:
|
5.88 |
|
10-Days: |
13566 |
Low: |
1.55 |
|
RSI |
RSI(14):
|
43.15 |
Change(%): |
-41.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-1028.9 |
Shares Out. (M) |
3.92 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-352.3 |
Shares Float (M) |
3.78 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.70 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.70 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
91 |
|
Book Value (p.s.) |
3.230 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.64 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.52 |
P/S |
80752000.00 |
|
Operating Margin |
-1985.20 |
Levered Free Cash Flow
(M) |
-2.62 |
P/CF |
-1.46 |
|
|
|
|
|
|
